CCMG
IDXX icon

Clark Capital Management Group’s Idexx Laboratories IDXX Stock Holding History

Clark Capital Management Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$228K Buy
405
+34
+9% +$21.8K ﹤0.01% 492
2025
Q4 		$251K Buy
+371
New +$253K ﹤0.01% 452

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clark Capital Management Group's IDXX Position: Q1 2026 in Review

Clark Capital Management Group increased its Idexx Laboratories (IDXX) stake by 9.2% in Q1 2026, buying an estimated $21.8K and bringing the position to 405 shares worth $228K. The position accounts for ﹤0.01% of the portfolio, ranked #492.

Clark Capital Management Group first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. The position peaked at $251K in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Clark Capital Management Group held 405 shares of Idexx Laboratories worth $228K as of Q1 2026.
  • Clark Capital Management Group bought 34 Idexx Laboratories shares in Q1 2026, an estimated $21.8K.
  • Idexx Laboratories made up ﹤0.01% of Clark Capital Management Group's portfolio in Q1 2026, its #492 holding.
  • Clark Capital Management Group first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Clark Capital Management Group's Idexx Laboratories position peaked at $251K in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Clark Capital Management Group's 13F filing for Q1 2026, filed 15 May 2026.